The development of resistance against tuberculosis in guinea pigs vaccinated with defatted tubercle bacilli was reported in earlier publications from this laboratory [see Fregnan and Smith (1963) for a more complete bibliography] as well as from other laboratories (Weiss and Wells, 1960; Tsumita et al., 1960) . Contrary findings have been published by several investigators (Raffel, 1946; Frappier, Portelance, and St. Pierre, 1959) . This paper presents the results of experiments designed to further fractionate defatted tubercle bacilli with the aimn of eliminating inert substances and, if possible, bringing about the separation of the factors responsible for the induction of resistance and delayed sensitivity. MATERIALS AND METIODS Animals. Male and female guinea pigs, primarily albino but some mixed colors, weighing 500 to 800 g were obtained from a local supplier. They were fed standard guinea pig chow and were water-supplemented daily with vitamin C (160 ,4g/ml). Guinea pigs were randomly allocated to 15 groups, each containing 18 animals, and were housed in groups of 2 to 4 in stainless-steel cages.
Strain of Mycobacterium. Most of the defatted vaccines and the challenge inoculum were prepared from a strain of Mycobacterium tuberculosis (NIH-199RB) obtained from B. J. Olson in 1947, and maintained since that time by semiannual transfers on American Trudeau Society medium. One defatted vaccine was prepared from a culture of H37Ra obtained from E. H. Runyon in 1956 and maintained as indicated above.
Preparations of defatted bacillus (DFB) vaccine. A brief description of the various vaccines used in this experiment is given; additional details about each preparation will be supplied on request. Since these substances are crude cell residues that will require further fractionation, no chemical analvsis is given at this time.
DFB-H37Ra vaccine was prepared from a 10-day-old culture of H37Ra in Dubos broth (no albumin) with 1.5% glycerol. The live cells were extracted sequentially with ether-ethanol, chloroform, and methanol-chloroform. The final residue was acid-fast and nonviable. DFB-199GP vaccine was prepared from a culture of M. tuberculosis 199RB freshly isolated from a guinea pig. Other details of preparation are the same as described for DFB-H37Ra.
The preparation of lot 3 of DFB vaccine was described previously (Fregnan and Smith, 1963) .
Vaccines derived from the disruption of DFB lot 3. The essential steps in the preparation of various vaccines from DFB lot 3 are summarized in Fig. 1 . Disintegration was carried out in a Nossal (1953) Challenge. The challenge suspension was prepared from a 9-day-old culture of ill. tuberculosis 199RB, isolated from a mouse spleen and in its second passage in Tween-albumin medium. The culture was diluted to 10-5 in saline containing one part in ten of Tween-albumin medium. Plate counts made on Dubos oleic acid albumin agar (Difco) indicated that each animal received approximately 104 viable units. The challenge culture was maintained in uniform suspension by a magnetic stirrer during the infection procedure. Each animal received 1.0 ml of suspension subcutaneously over the sternum 5 months after the first vaccination.
Autopsy procedure. Six weeks after challenge, the guinea pigs were killed by the intraperitoneal injection of 2.0 ml of pentobarbital sodium (60 mg/ml). Observations were made in the following sequence: body weight, axillary and inguinal lymph nodes, tracheobronchial and retrosternal nodes, lung, liver, spleen, and spleen weight. The tracheobronchial nodes, lungs, and heart were fixed as one aggregate of tissue. The extent of gross tuberculosis was recorded according to a modification of the Feldman (1943) The final group of fractions was prepared from DFB lot 3 in an attempt to obtain a residue as free as possible from the adjuvant-soluble fraction. This was accomplished by interrupting the disintegration process at 3-min intervals, separating the residue by centrifugation, and returning it to the Nossal capsule with fresh adjuvant. This process was repeated three times. The final residue was washed with hexane and water, and vaccines were prepared from the water-soluble fraction and the final residue. The results indicate that the water-soluble fraction, DFB-AR-Water Soluble, was devoid of immunizing or hypersensitizing activity, whereas the residue, DFB-AR-Purified, possessed the same activity as DFB-AR.
The most potent vaccine seen in this experiment was DFB-199GP, the preparation of DFB derived from a fresh guinea pig passage of M. tuberculosis 199RB. In contrast, the DFB preparation made from H37Ra, DFB-H37Ra, was significantly less immunogenic. BCG induced a level of acquired resistance equivalent to DFB-AR, but with a lower level of sensitivity.
In Table 1 on October 2, 2017 by guest http://jb.asm.org/ Downloaded from DISCUSSION In this paper, attempts to increase the immunizing potency of defatted tubercle bacilli are reported. Separation of the immunizing and hypersensitizing constituents was also attempted. The only available assay for measuring these two biological activities is the immunization and challenge of experimental animals. Guinea pigs were chosen to make a simultaneous study of immunogenic and allergenic potencies of the various vaccines. A challenge-sacrifice type of evaluation was chosen for reasons given earlier (Fregnan and Smith, 1963) .
Loss of acid-fast staining property was used as evidence that a change had been brought about in the DFB vaccine and was noted after disintegration in the Nossal apparatus and after extraction with alkaline ethanol. Several investigators have employed the acid-fast stain to determine the degree of contamination of cell walls of mycobacteria by relatively intact acidfast bacilli (Kotani et al., 1960; Kanai, 1962) . Electron microscope studies of some of the adjuvant residue vaccines used in these experiments suggest that protoplasmic constituents adherent to cell-wall fragments are present.
One of the extraction procedures employed in this study in an attempt to bring about a further resolution of the mixture of components of DFB was the method of Cummins and Harris (1958) . This procedure involves extraction with alkaline ethanol, followed by disintegration and enzyme digestion. In a previous report (Erikson and Smith, 1962) , it was shown that DFB extracted with alkaline ethanol lost its acid-fast character but retained its immunogenicity for guinea pigs. In the current work, alkaline ethanolextracted DFB was subjected to Nossal disintegration either in adjuvant or in water, and the resulting residues were digested with ribonuclease, pepsin, and trypsin. A reduction of immunogenicity and allergenicitv was noted for both preparations. The loss of sensitizing activity for the residue of alkaline ethanol-extracted cells disintegrated in this manner was similar to the results obtained by Kanai, Youmans, and Youmans (1960) with alkaline ethanol-extracted cell walls.
In a previous experiment (Fregnan and Smith, 1963) , it was shown that DFB disrupted in adjuvant was more immunogenic than DFB disrupted in saline. Similar findings were reported (Fregnan and Smith, 1963) , some immunogenicity was detected in the fraction remaining in the adjuvant supernatant fluid after centrifugation at 44,000 X g; therefore, an attempt was made in the current experiment to obtain a more clear-cut separation of adjuvantsoluble and -insoluble fractions. This was accomplished by repeated centrifugation of the products of disintegration at 44,000 X g followed by centrifugation at 105,000 x g. Immunogenicity l'OL. 88,y 1964 was detected only in the residue separated from DFB by centrifugation at 44,000 X g.
It should be noted that while 50 ,ug of DFB-AR given subcutaneously in adjuvant produced high levels of immunity and sensitivity, the same quantity given by the intraperitoneal route in saline was devoid of activity.
DFB vaccines prepared from an avirulent strain of niycobacterium (H37Ra) and from a recently passed virulent strain gave significantly different levels of protection, whereas levels of hypersensitivity were the same. Further studies will be required to confirm this observation and to determine whether such differences can be obtained for the residues of these two vaccines after disruption.
Comparison of the mean immunogenic and allergenic potencies of the various substances tested in these experiments gives no evidence that different fractions are responsible for the two activities. In fact, with the exception of BCG and DFB-H37Ra, a good correlation exists between the mean immunogenic and allergenic activities of the various vaccines.
